MVX0006 Phase I

Apr 3, 2023 | Clinical Trials

Clinical Trials

Immunogenecity and Safety of GBS-NN/NN2 in Older Adults

Description:

Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants.

Status:

Study is currently enrolling

Countries:

Belgium

Clinicaltrials.gov